Table 2 Cliniopathological characteristics of patients with mantle cell lymphoma.

From: Classification of aggressive and classic mantle cell lymphomas using synchrotron Fourier Transform Infrared microspectroscopy

Case No.

Age

Sex

Histological type

Cyclin D1

Ki 67 index

First-line treatment

Relapse

Next-line treatment

Long term follow-up

50

ND

F

blastoid/pleomorphic

positive

90

RCHOP

ND

ND

ND

6

82

M

blastoid/pleomorphic

positive

90

RCHOP

yes

R-Benda

Death

7

59

F

blastoid/pleomorphic

negative

100

RCHOP

yes

R-Benda

Death

22

ND

ND

blastoid/pleomorphic

positive

80

ND

ND

ND

ND

27

70

M

blastoid/pleomorphic

positive

70–80

RCHOP

yes

R-Benda

Alive

4

76

F

classic

positive

40

RCVP

yes

R-Benda

Alive

8

70

F

classic

positive

20

RCHOP

no

no

Alive

18

67

M

classic

positive

30

ND

ND

ND

ND

21

70

F

classic

positive

20–40

RCP

yes

R-Benda

Alive

23

86

M

classic

positive

20

ND

ND

ND

ND

25

75

F

classic

positive

40–50

RCHOP

yes

Benda

Alive

28

68

M

classic

positive

50

RCHOP

no

no

Alive

30

86

M

classic

positive

30–50

R-Benda

no

no

Death

32

75

F

classic

positive

40–50

RCHOP

no

no

Death

36

88

F

blastoid/pleomorphic

positive

40

COP

ND

ND

Death

37

83

M

blastoid/pleomorphic

positive

80

RCOP/RCP

ND

ND

Alive

39

70

F

blastoid/pleomorphic

positive

50

RCHOP

ND

ND

Death

40

76

M

blastoid/pleomorphic

positive

90

RCHOP

ND

ND

Death

  1. (Abbreviations: RCHOP = Rituximab, Cyclophosphamide, Doxorubicin (Hydroxydaunomycin), Vincristine (Oncovin), Prednisolone; RCVP = Rituximab, Cyclophosphamide, Vincristine, Prednisolone; RCP = Rituximab, Cyclophosphamide, Prednisolone; COP = Cyclophosphamide, Vincristine (Oncovin), Prednisolone; R-Benda = Rituximab, Bendamustine; ND = no data).